Last updated: July 17, 2026

Application No. 18/424,360

PHARMACEUTICAL COMPOSITION AND ANTI-TUMOR AGENT FOR TUMOR HAVING DECREASED FUNCTION OF AT LEAST ONE OF BAP1 OR PBRM1

Non-Final OA

Filed

Jan 26, 2024

Priority

Jul 29, 2021 — provisional 63/227,035 +1 more

Examiner

SCHACHERMEYER, SAMANTHA LYNN

Art Unit

Tech Center

Assignee

Fujifilm Corporation

OA Round

1 (Non-Final)

This examiner grants 38% of cases after interview

— +69.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 34 resolved cases, 2023–2026

Examiner Intelligence

SCHACHERMEYER, SAMANTHA LYNN View full profile →

Grants only 38% of cases

Career Allowance Rate

13 granted / 34 resolved

-21.8% vs TC avg

Strong +70% interview lift

Without

With

+69.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

28 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

82.6%

+42.6% vs TC avg

§102

4.5%

-35.5% vs TC avg

§112

2.6%

-37.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 34 resolved cases

Prosecution Timeline

Jan 26, 2024

Application Filed

Apr 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/763,887

Patent 12616711

THERAPEUTIC DENDRIMER

4y 1m to grant Granted May 05, 2026

17/785,809

Patent 12594258

INHIBITORS OF MHC-I NEF DOWNMODULATION FOR TREATING HIV

3y 9m to grant Granted Apr 07, 2026

17/914,634

Patent 12582656

NUCLEOTIDE ANALOGUES

3y 6m to grant Granted Mar 24, 2026

17/773,670

Patent 12545699

BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA

3y 9m to grant Granted Feb 10, 2026

18/010,112

Patent 12516081

ANTI-VIRAL COMPOUNDS AND METHODS OF USE

3y 0m to grant Granted Jan 06, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

38%

Grant Probability

99%

With Interview (+69.7%)

3y 3m (~10m remaining)

Median Time to Grant

Low

PTA Risk

Based on 34 resolved cases by this examiner. Grant probability derived from career allowance rate.